VTRX

Dow Struggles at 18,000 as Earnings Weigh

By Anthony Mirhaydari, InvestorPlace Market Strategist
The market's best chance for a near-term catalyst from here? A sign that the Fed will push back a hike in rates.

5 Biotech Stocks to Short

By Anthony Mirhaydari, InvestorPlace Market Strategist
Biotech stocks have been severely overbought in the last several months and are beginning to turn, one by one. That makes them ripe pickings for short sellers. Here are five in the biotech field to short.